CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer

Published:2024-08 Issue: Volume:177 Page:116972
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chen Wenmin,Wu Yue,Yang Chuanyu,Ren Wenlong,Hou Lei,Liang Huichun,Wu Tingyue,Kong Yanjie,Wu Jiao,Rao Yu,Chen Ceshi^ORCID

Funder

Science and Technology Department of Yunnan Province

China Postdoctoral Science Foundation

Department of Science and Technology of Guangdong Province

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Publisher

Elsevier BV

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Cancer incidence and mortality in China, 2016;Zheng;J. Natl. Cancer Cent.,2022

3. Breast cancer statistics, 2019;DeSantis;CA Cancer J. Clin.,2019

4. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer;Wang;BMC Cancer,2019

5. Breast cancer;Harbeck;Nat. Rev. Dis. Prim.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP